Guardant Health, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for GH, updated each market day.
GH AI Sentiment
AI sees no strong directional signal for Guardant Health, Inc. Common Stock stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Guardant Health, Inc. Common Stock
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Sector
Exchange
Market Cap
$24,571,318,727
Cap Tier
Employees
2,506
Headquarters
PALO ALTO, CA
Listed Since
Oct. 4, 2018
Website
GH Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
GH Volatility
Guardant Health, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
